Artikel ; Online: GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)? A systematic review.
Journal of clinical & translational endocrinology
2024 Band 35, Seite(n) 100333
Abstract: Objective: Systematically review evidence on using GLP-1RAs for reducing BEB in BED and BN.: Methods: Comprehensive literature search (PubMed and Google Scholar) conducted for studies evaluating GLP-1Ras for BEB. Extracted data on study ... ...
Abstract | Objective: Systematically review evidence on using GLP-1RAs for reducing BEB in BED and BN. Methods: Comprehensive literature search (PubMed and Google Scholar) conducted for studies evaluating GLP-1Ras for BEB. Extracted data on study characteristics, efficacy, and safety. Results: Studies show that GLP-1RAs (liraglutide and dulaglutide) reduce BE frequency and comorbidities in addition to favorable psychiatric side effect profile compared to current options. However, large-scale, blinded placebo-controlled trials are lacking. Conclusion: Early findings suggest promising effects of GLP-1RAs on BEB. However, rigorous clinical trials are needed to firmly establish efficacy, dosing, safety, and comparative effectiveness before considering GLP-1RAs a viable novel approach. |
---|---|
Sprache | Englisch |
Erscheinungsdatum | 2024-02-29 |
Erscheinungsland | Netherlands |
Dokumenttyp | Journal Article ; Review |
ZDB-ID | 2834222-7 |
ISSN | 2214-6237 ; 2214-6237 |
ISSN (online) | 2214-6237 |
ISSN | 2214-6237 |
DOI | 10.1016/j.jcte.2024.100333 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.